{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:09:45Z","timestamp":1784153385785,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Observational studies have shown that hyperthyroidism may increase the risk of cancer, but their causal effects and direction are unclear. We conducted a two-sample Mendelian randomization (MR) study to explore the associations between genetic predisposition to hyperthyroidism and nine common types of cancer, including prostate, lung, breast, colon, leukemia, brain, skin, bladder, and esophagus cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We obtained summary statistics of hyperthyroidism and nine types of cancers from genome-wide association studies (GWAS). MR analysis is performed to investigate the potential causal relationship between hyperthyroidism and cancers. The inverse variance weighted (IVW) as the primary method was carried out. The robustness of the results was evaluated by sensitivity analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Genetically predicted hyperthyroidism was associated with a declining risk of occurrence of prostate cancer (odds ratio (OR)<jats:sub>IVW<\/jats:sub>= 0.859, P= 0.0004; OR <jats:sub>MR-Egger<\/jats:sub>=0.828, P= 0.03; OR <jats:sub>weighted median<\/jats:sub>= 0.827, P=0.0009). Additionally, there was a significant association between genetically predicted hyperthyroidism and colon cancer (OR <jats:sub>IVW<\/jats:sub>= 1.13, P= 0.011; OR <jats:sub>MR-Egger<\/jats:sub>= 1.31, P= 0.004; OR <jats:sub>weighted median<\/jats:sub>= 1.18, P= 0.0009). Hyperthyroidism was also suggestively correlated with a higher risk of leukemia based on the result of IVW and weighted median (OR <jats:sub>IVW<\/jats:sub>= 1.05, P= 0.01; OR <jats:sub>weighted median<\/jats:sub>= 1.08, P= 0.001). Results from a two-sample MR analysis suggested that hyperthyroidism was not associated with the risk of lung cancer, breast cancer, brain cancer, skin cancer, bladder cancer, and esophageal cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study provides evidence of a causal relationship between hyperthyroidism and the risk of prostate cancer, rectal cancer, and leukemia. Further research is needed to clarify the associations between hyperthyroidism and other cancers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1162224","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T07:56:09Z","timestamp":1684396569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Causal associations of hyperthyroidism with prostate cancer, colon cancer, and leukemia: a Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Feipeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet (Lond Engl)."},{"key":"B2","article-title":"Thyroid hormone receptors: multiple forms, multiple possibilities","volume":"14","author":"Lazar","year":"1993","journal-title":"Endocrine Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05018-z","article-title":"Higher thyroid hormone levels and cancer","volume":"48","author":"Petranovic Ovcaricek","year":"2021","journal-title":"Eur J Nucl Med Mol Imag."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32988","article-title":"Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: a two-sample mendelian randomization study","volume":"147","author":"Yuan","year":"2020","journal-title":"Int J Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-227132","article-title":"Nuclear monomeric integrin alphav in cancer cells is a coactivator regulated by thyroid hormone","volume":"27","author":"Lin","year":"2013","journal-title":"FASEB J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0102","article-title":"Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1768","article-title":"Thyroid hormone responsive genes in cultured human fibroblasts","volume":"90","author":"Moeller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2009","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2104","article-title":"Thyroid function and cancer risk: the Rotterdam study","volume":"101","author":"Khan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0911","article-title":"Thyroid function and cancer risk: a prospective population study","volume":"18","author":"Hellevik","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5808\/GI.2016.14.4.173","article-title":"Comparison of two meta-analysis methods: inverse-Variance-Weighted average and weighted sum of z-scores","volume":"14","author":"Lee","year":"2016","journal-title":"Genomics Inform"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14583","DOI":"10.1038\/s41598-021-93979-y","article-title":"A mendelian randomization analysis of the relationship between cardioembolic risk factors and ischemic stroke","volume":"11","author":"Tian","year":"2021","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0417","article-title":"Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis","volume":"27","author":"Tran","year":"2020","journal-title":"Endocrine-related Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"djv084","DOI":"10.1093\/jnci\/djv084","article-title":"Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk","volume":"107","author":"Boursi","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3755","article-title":"Association between thyroid disorders and colorectal cancer risk in adult patients in Taiwan","volume":"2","author":"L'Heureux","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EJE-17-0197","article-title":"Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer","volume":"177","author":"Chan","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047730","article-title":"Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer","volume":"7","author":"Mondul","year":"2012","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.03.011","article-title":"Thyroid receptor: roles in cancer","volume":"20","author":"Aranda","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13260","article-title":"Thyroid hormones in diabetes, cancer, and aging","volume":"19","author":"Gauthier","year":"2020","journal-title":"Aging Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150035","article-title":"Thyroid hormone, cancer, and apoptosis","volume":"6","author":"Lin","year":"2016","journal-title":"Compr Physiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/genes13122214","article-title":"Cuproptosis-related lncRNA gene signature establishes a prognostic model of gastric adenocarcinoma and evaluate the effect of antineoplastic drugs","volume":"13","author":"Tu","year":"2022","journal-title":"Genes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Sci (New York NY)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study","volume":"174","author":"Sogaard","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64161-4","article-title":"Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia","volume":"168","author":"Lehrer","year":"2002","journal-title":"J urology."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2010.11680671","article-title":"A new risk factor in oesophageal cancer aetiology: hyperthyroidism","volume":"110","author":"Turkyilmaz","year":"2010","journal-title":"Acta chirurgica Belgica"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.942155","article-title":"The relationship between processed meat, red meat, and risk of types of cancer: a mendelian randomization study","volume":"9","author":"Wu","year":"2022","journal-title":"Front Nutr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synthesis Methods"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx192","article-title":"Misconceptions on the use of MR-egger regression and the evaluation of the InSIDE assumption","volume":"46","author":"Bowden","year":"2017","journal-title":"Int J Epidemiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1162224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T07:56:13Z","timestamp":1684396573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1162224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":33,"alternative-id":["10.3389\/fendo.2023.1162224"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1162224","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"article-number":"1162224"}}